169 related articles for article (PubMed ID: 12853767)
1. Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism.
Lin G; Xin ZC; Lue TF; Lin CS
J Urol; 2003 Aug; 170(2 Pt 2):S15-8; discussion S19. PubMed ID: 12853767
[TBL] [Abstract][Full Text] [Related]
2. Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes.
Zhang XH; Filippi S; Morelli A; Vignozzi L; Luconi M; Donati S; Forti G; Maggi M
J Sex Med; 2006 Mar; 3(2):253-64; discussion 264-5, author reply 265-6. PubMed ID: 16490018
[TBL] [Abstract][Full Text] [Related]
3. Improving erectile function by silencing phosphodiesterase-5.
Lin G; Hayashi N; Carrion R; Chang LJ; Lue TF; Lin CS
J Urol; 2005 Sep; 174(3):1142-8. PubMed ID: 16094082
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil inhibits the up-regulation of phosphodiesterase type 5 elicited with nicotine and tumour necrosis factor-alpha in cavernosal vascular smooth muscle cells: mediation by superoxide.
Hotston MR; Jeremy JY; Bloor J; Koupparis A; Persad R; Shukla N
BJU Int; 2007 Mar; 99(3):612-8. PubMed ID: 17176295
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle.
Park K; Moreland RB; Goldstein I; Atala A; Traish A
Biochem Biophys Res Commun; 1998 Aug; 249(3):612-7. PubMed ID: 9731184
[TBL] [Abstract][Full Text] [Related]
6. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures.
Valente EG; Vernet D; Ferrini MG; Qian A; Rajfer J; Gonzalez-Cadavid NF
Nitric Oxide; 2003 Dec; 9(4):229-44. PubMed ID: 14996430
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase-5 isoforms: differential cyclic guanyl monophosphate binding and cyclic guanyl monophosphate catalytic activities, and inhibitory effects of sildenafil and vardenafil.
Lin G; Xin ZC; Lue TF; Lin CS
J Urol; 2006 Sep; 176(3):1242-7. PubMed ID: 16890733
[TBL] [Abstract][Full Text] [Related]
8. Tachyphylaxis and phosphodiesterase type 5 inhibitors.
Steers WD
J Urol; 2002 Jul; 168(1):207. PubMed ID: 12050542
[No Abstract] [Full Text] [Related]
9. Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats.
Shukla N; Rossoni G; Hotston M; Sparatore A; Del Soldato P; Tazzari V; Persad R; Angelini GD; Jeremy JY
BJU Int; 2009 Jun; 103(11):1522-9. PubMed ID: 19245441
[TBL] [Abstract][Full Text] [Related]
10. The presence and function of phosphodiesterase type 5 in the rat myometrium.
Buhimschi CS; Garfield RE; Weiner CP; Buhimschi IA
Am J Obstet Gynecol; 2004 Jan; 190(1):268-74. PubMed ID: 14749671
[TBL] [Abstract][Full Text] [Related]
11. T-0156, a novel phosphodiesterase type 5 inhibitor, and sildenafil have different pharmacological effects on penile tumescence and electroretinogram in dogs.
Mochida H; Noto T; Inoue H; Yano K; Kikkawa K
Eur J Pharmacol; 2004 Feb; 485(1-3):283-8. PubMed ID: 14757152
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of phosphodiesterase-5 inhibitors on hypoxic pulmonary vasoconstriction and pulmonary artery cytokine expression.
Tsai BM; Turrentine MW; Sheridan BC; Wang M; Fiore AC; Brown JW; Meldrum DR
Ann Thorac Surg; 2006 Jan; 81(1):272-8. PubMed ID: 16368379
[TBL] [Abstract][Full Text] [Related]
13. Type V phosphodiesterase expression in cerebral arteries with vasospasm after subarachnoid hemorrhage in a canine model.
Inoha S; Inamura T; Ikezaki K; Nakamizo A; Amano T; Fukui M
Neurol Res; 2002 Sep; 24(6):607-12. PubMed ID: 12238630
[TBL] [Abstract][Full Text] [Related]
14. Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum.
Qiu Y; Kraft P; Lombardi E; Clancy J
J Urol; 2000 Sep; 164(3 Pt 1):882-6. PubMed ID: 10953172
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of phosphodiesterase 5 (PDE 5) inhibit the nerve-induced release of nitric oxide from the rabbit corpus cavernosum.
Hallén K; Wiklund NP; Gustafsson LE
Br J Pharmacol; 2007 Feb; 150(3):353-60. PubMed ID: 17179943
[TBL] [Abstract][Full Text] [Related]
16. Sildenafil causes a dose- and time-dependent downregulation of phosphodiesterase type 6 expression in the rat retina.
Gonzalez CM; Bervig T; Podlasek C; Huang CF; McKenna KE; McVary KT
Int J Impot Res; 1999 Sep; 11 Suppl 1():S9-14. PubMed ID: 10554924
[TBL] [Abstract][Full Text] [Related]
17. Acute priapism associated with the use of sildenafil in a patient with sickle cell trait.
Kassim AA; Fabry ME; Nagel RL
Blood; 2000 Mar; 95(5):1878-9. PubMed ID: 10744389
[No Abstract] [Full Text] [Related]
18. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.
Das A; Xi L; Kukreja RC
J Biol Chem; 2005 Apr; 280(13):12944-55. PubMed ID: 15668244
[TBL] [Abstract][Full Text] [Related]
19. Review of phosphodiesterases in the urogenital system: new directions for therapeutic intervention.
Montorsi F; Corbin J; Phillips S
J Sex Med; 2004 Nov; 1(3):322-36. PubMed ID: 16422964
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of sildenafil analogues from anacardic acid and their phosphodiesterase-5 inhibition.
Paramashivappa R; Phani Kumar P; Subba Rao PV; Srinivasa Rao A
J Agric Food Chem; 2002 Dec; 50(26):7709-13. PubMed ID: 12475293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
